martes, 24 de septiembre de 2019

Biotech startup hopes to disarm cancer by targeting a genetic bandolier

Biotech startup hopes to disarm cancer by targeting a genetic bandolier

Cancer Briefing

STAT Plus: A biotech startup hopes to disarm cancer by targeting a genetic bandolier

By DAMIAN GARDE


ALEX HOGAN/STAT
The company, Boundless, traces its roots to the discovery that extrachromosomal DNA is far more common in cancer cells than previously thought.

No hay comentarios: